Mahima Datla

$3.02B
$5.7M (-0.2%)
as of 08/18/26

About Mahima Datla

Mahima Datla is the managing director of Biological E, a privately held vaccine producer, in which she holds a controlling stake.

The Hyderabad-based company's portfolio includes Corbevax, a Covid-19 vaccine developed in partnership with Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston.

Biological E has 10 vaccines pre-qualified by the World Health Organization including those against polio, tetanus and measles. It exports vaccines to more than 130 countries.

Biological E was founded in 1953 by her paternal and maternal grandfathers.

In July 2025 Bioligcal E struck a licensing agreement with China's Jiangsu Recbio Technology to manufacture and commercialize HPV vaccines to combat cancer.

Personal stats

Citizenship

India

Source of wealth

Vaccines

Residence

Hyderabad, India

Marital status

Single

Birth date

07/16/77 (age 49)

Education

Bachelor of Business Administration, Webster University

Self-made

inherited and growing

Mahima Datla’s fortune is worth

50K

troy ounces of gold

46K

median U.S. household

30K

median U.S. income

0.06%

U.S. credit card volume

0.012%

GDP of the United States

0.009%

United States debt

Net worth history

Annual ranking

Did you know?

Datla has a bachelor's degree in business management from London's Webster University. She became managing director in 2013.

Net worth over time

Real-time ranking

Images © Forbes.com. All rights reserved.